Cellegy Announces Update to Savvy Phase 3 HIV Prevention Trials (Herpes)

Cellegy Announces Update to Savvy Phase 3 HIV Prevention Trials
PR Newswire (press release), NY - Oct 27, 2005 100% enrollment has been achieved in the Savvy(R) (C31G vaginal gel) Phase sexually transmitted diseases (STDs), including those caused by herpes simplex virus

Stressed? That's why yeast love you
ABC Science Online, Australia - Oct 27, 2005 They also found that more patients than controls had a history of other vaginal infections such as genital warts, bacterial vaginosis and genital herpes.

Indevus Announces Initiation of Phase III Trial of PRO 2000
Genetic Engineering News, NY - Oct 25, 2005 PRO 2000, the Company's topical, vaginal microbicide in development for the prevention of sexually transmitted infections, including HIV, herpes, chlamydia and

The snip could save many lives
The South African Star (subscription), South Africa - 19 hours ago in situations where the male is the insertive partner in vaginal or rectal include the use of the female diaphragm, acyclovir to suppress herpes (as herpes is

MEDIVIR, INTERIM REPORT, 1 January 30 September 2005
Biotech Intelligence (press release), France - Oct 26, 2005 Phase II study data on the labial herpes (cold sores) indication demonstrates with early the rights to MIV-150 for topical usage in a vaginal microbicide in

Herpes